crexont
Generic: carbidopa and levodopa
Labeler: amneal pharmaceuticals llcDrug Facts
Product Profile
Brand Name
crexont
Generic Name
carbidopa and levodopa
Labeler
amneal pharmaceuticals llc
Dosage Form
CAPSULE, EXTENDED RELEASE
Routes
Active Ingredients
carbidopa 52.5 mg/1, levodopa 210 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
64896-968
Product ID
64896-968_34302a9d-0ae4-4931-b641-eecc81b70922
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA217186
Listing Expiration
2026-12-31
Marketing Start
2024-08-09
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
64896968
Hyphenated Format
64896-968
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
crexont (source: ndc)
Generic Name
carbidopa and levodopa (source: ndc)
Application Number
NDA217186 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 52.5 mg/1
- 210 mg/1
Packaging
- 1 BOTTLE in 1 CARTON (64896-968-16) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
- 1 BOTTLE in 1 CARTON (64896-968-23) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "34302a9d-0ae4-4931-b641-eecc81b70922", "openfda": {"nui": ["N0000193220", "M0370111", "N0000175754", "N0000175755"], "upc": ["0364896968166", "0364896969163", "0364896967169"], "unii": ["46627O600J", "MNX7R8C5VO"], "rxcui": ["2690259", "2690265", "2690279", "2690281", "2690284", "2690286", "2690290", "2690292"], "spl_set_id": ["095a08b6-b0b8-4f88-b759-67e8b87287a0"], "pharm_class_cs": ["Amino Acids, Aromatic [CS]"], "pharm_class_epc": ["Aromatic Amino Acid [EPC]", "Aromatic Amino Acid Decarboxylation Inhibitor [EPC]"], "pharm_class_moa": ["DOPA Decarboxylase Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (64896-968-16) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "64896-968-16", "marketing_start_date": "20240809"}, {"sample": true, "description": "1 BOTTLE in 1 CARTON (64896-968-23) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "64896-968-23", "marketing_start_date": "20240809"}], "brand_name": "CREXONT", "product_id": "64896-968_34302a9d-0ae4-4931-b641-eecc81b70922", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Amino Acids", "Aromatic [CS]", "Aromatic Amino Acid [EPC]"], "product_ndc": "64896-968", "generic_name": "carbidopa and levodopa", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CREXONT", "active_ingredients": [{"name": "CARBIDOPA", "strength": "52.5 mg/1"}, {"name": "LEVODOPA", "strength": "210 mg/1"}], "application_number": "NDA217186", "marketing_category": "NDA", "marketing_start_date": "20240809", "listing_expiration_date": "20261231"}